Navigation Links
First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008
Date:3/24/2009

en's University Belfast)
  • Project dedicated to assessing civil conflict risks (Universitat Autonoma of Barcelona)
  • Project entitled A structural approach to inflation and term structure (EDHEC Business School of Lille)
  • 58 young researchers of promise, working in 13 countries

    • 28 postdoctoral fellowships of Euro 60,000 each
    • 30 doctoral fellowships of Euro 120,000 each

    "The AXA Research Fund chose to help outstanding institutions widen their reach in a sustainable manner, through capital endowments, a tool that is very new to Western Europe," said Ezra Suleiman, president of the Scientific Board. "We wanted to guarantee absolute independence and freedom to the researchers who receive our funding, since they are critical to success. We plan to pursue our action in 2009, and will bolster the international dimension of our investments."

    Information about the AXA Research Fund, in particular that pertaining to the selection criteria and process for researchers and institutions interested in being considered for financial assistance can be found at our website: http://researchfund.axa.com

    About AXA

    AXA Group is a worldwide leader in Financial Protection. AXA's operations are diverse geographically, with major operations in Europe, North America and the Asia/Pacific area. For full year 2008, IFRS revenues amounted to Euro 91.2 billion and IFRS adjusted earnings to Euro 3.7 billion. AXA had Euro 981 billion in assets under management as of December 31, 2008.

    The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISIN FR0000120628 - Bloomberg: CS FP - Reuters: AXAF.PA). The American Depository Share is also listed on the NYSE under the
    '/>"/>

    SOURCE AXA Group
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
    2. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
    3. First Swiss Patients Treated with the Percutaneous MitraClip(R) System
    4. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
    5. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
    6. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
    7. Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
    8. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
    9. Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
    10. First U.S. Patients Enrolled in the REALISM Continued Access Study
    11. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... and SAN DIEGO , Dec. 17, 2014 ... ; AEX: PHIA) and Volcano Corporation (NASDAQ: VOLC ... for cardiovascular applications, today announced that they have entered into ... commence a tender offer to acquire all of the issued ... or a total equity purchase price of USD 1 billion ...
    (Date:12/17/2014)... 2014  Northstar Global Business Services, Inc. (OTCPink:MDIN) ... has made their final decision and has determined ... stock effective December 15, 2014, and has resumed ... and book entry transfer services. All deposit restrictions have ... again fully "DTC Eligible", and has resumed electronic ...
    (Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
    Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
    (Date:12/21/2014)... Viejo, California (PRWEB) December 21, 2014 ... Studios have announced a new intro plugin for Final ... to animate pictures, videos, logos, and more with absolute ... “We’ve given our users the tools needed to easily ... ProMotion allows Final Cut Pro X users to animate ...
    (Date:12/21/2014)... Concept Plus, LLC. a SDB and 8(a) ... VA., today announced it has been recognized by Washington ... ranks the fastest growing government contracting small businesses by calculating ... This is the first year that Concept Plus, LLC., participated ... a 95.92% compound annual growth rate. “For Concept Plus to ...
    (Date:12/20/2014)... 20, 2014 Weddingshe.com has recently announced ... a site-wide promotion of special occasion dresses for the ... supplier of special occasion dresses for global women. Now, ... big discounts, up to 80% off. Among the new ... Short Sweet 16 Dress) is very popular. What’s more, ...
    (Date:12/20/2014)... (PRWEB) December 20, 2014 The print ... Post, with a distribution of approximately 160,000 copies and ... distributed nationally through a vast social media strategy and ... outlets. To explore the digital version of the campaign, ... exclusive interview with the ladies of CTV’s The ...
    (Date:12/20/2014)... 20, 2014 Angeldress.co.uk, the distinguished wedding ... for worldwide dress fans. The company has recently updated ... information. For the holiday season, Angeldress Blog ... wedding apparel. , Angeldress.co.uk prides itself in offering a ... of service. All the company’s outfits are very carefully ...
    Breaking Medicine News(10 mins):Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2
    ... about the brain affect the course of a criminal trial, ... a sentence? This was the topic of ... for Neuroscience,s "Neuroscience 2011." Titled "The Brain on Trial: Neuroscience ... neuroscience are both challenging and assisting the judicial system. To ...
    ... SUNDAY, Dec. 11 (HealthDay News) -- A drug called ... cell anemia can also help young children with the disease, ... younger than 4 years old who took the medication had ... with fever and need for transfusions, the study found. ...
    ... leukemia patients, own infection-fighting cells appears to protect ... with fludarabine-based chemotherapy, according to new research from ... of Pennsylvania. The new process is a step ... from the commonly prescribed drug, which improves progression-free ...
    ... SAN DIEGO - A new, targeted approach to treating ... Phase I/II clinical trial for patients with relapsed or ... of the American Society of Hematology. "PCI-32765, one ... cell receptor inhibitors, has shown impressive potential in this ...
    ... FRIDAY, Dec. 9 (HealthDay News) -- Flu vaccination is easy ... your health during the flu season, but too few Americans ... off concerns about the flu, yet every year it strikes ... to the hospital and killing thousands," Dr. Thomas Slama, president ...
    ... Terrorist attacks with chemical weapons are a real possibility, ... access journal, Journal of Pharmacy Practice , published by ... how to treat those who have been exposed, pharmacists are ... potential chemical weapons attack. Chemical weapons act on their ...
    Cached Medicine News:Health News:The brain on trial 2Health News:Adult Sickle Cell Drug May Benefit Kids, Too 2Health News:Adult Sickle Cell Drug May Benefit Kids, Too 3Health News:Penn researchers repair immune system in leukemia patients following chemotherapy 2Health News:Penn researchers repair immune system in leukemia patients following chemotherapy 3Health News:B cell receptor inhibitor causes chronic lymphocytic leukemia remission 2Health News:Americans Encouraged to Get Flu Vaccine 2Health News:Pharmacists crucial in plan for terrorist chemical weapons 2
    ... The Centra B+ can be used as a ... the Centra W for AHG spins, or as ... 2 rotors, transparent cell washing rotor: easy to ... braking options, aerosol containment for vacutainers, glove friendly ...
    ... High speed refrigerated floor-standing centrifuge. ... lifetime reproducibility, informative display, display in ... TFT refrigeration, true sample temperature control, ... dual lid interlock, current and temperature ...
    ... Powerful refrigerated floor-standing centrifuge. Mobile ... rotors, large choice of accessories, analog ... detection & shutdown (JOUAN patented pendulum ... current and temperature limitation, rugged motor, ...
    Powerful refrigerated bench-top centrifuge. Very powerful, high capacity rotors, large choice of accessories, heat labile sample protection, guard barrier, dual lid interlock, easy to use, variable c...
    Medicine Products: